Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
about
From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptorAnti-HBV Drugs: Progress, Unmet Needs, and New HopeNTCP and beyond: opening the door to unveil hepatitis B virus entrySolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesImpact of hepatitis B virus infection on hepatic metabolic signaling pathwayHepatitis B virus molecular biology and pathogenesisThe Na(+)-Taurocholate Cotransporting Polypeptide Traffics with the Epidermal Growth Factor Receptor.Comprehensive assessment showed no associations of variants at the SLC10A1 locus with susceptibility to persistent HBV infection among Southern Chinese.Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expressionQuantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.Spinoculation Enhances HBV Infection in NTCP-Reconstituted HepatocytesA genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population.N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptideGlobal epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.In vivo models of hepatitis B and C virus infection.Organic anion uptake by hepatocytes.Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency.Importance of endocytic pathways in liver function and disease.Hepatitis B in 2014: HBV research moves forward--receptors and reactivation.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.Host genetic variants influencing the clinical course of hepatitis B virus infection.Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter.Immune balance in Hepatitis B Infection: Present and Future Therapies.Hepatitis B virus receptors and molecular drug targets.A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes.Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway In Vitro.Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine.Viral hepatitis: The bumpy road to animal models for HBV infection.Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures.The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.
P2860
Q26777485-10BFC222-0A02-4CDF-8403-A134878BA115Q26782742-8BA3CBCC-3D07-485A-B0D9-90A497B8E75FQ26999712-13F4E810-360E-49E3-899E-54A9BC2A5B77Q27928046-525E0CB4-EC7E-458B-BA76-1C515A96A9B9Q28072127-F99603D1-2C5F-4170-A62F-8F10404AD642Q28818406-5A2CA503-2157-49FE-AA13-7B1373C46BB8Q30717953-D3A62D12-9A71-460E-A491-2D4F64277831Q33587347-CECB0ED1-F8D2-4C8C-8545-4D7DD9845E4DQ35043978-3A6EE86F-2286-4657-943F-55F53453AF72Q35126674-608740D1-02E3-4AED-B344-FAEB2D54C515Q35185827-193D1E8D-9003-41D2-A69A-2799F34C8340Q35662475-7344865F-DF89-4F50-AC51-A73A66EA7072Q35954591-02A6F852-0592-4DC8-9EB9-FE5E18315DCEQ36260961-6DFAF267-466B-42CD-8858-3B9E9E746750Q36261626-B26E391E-9B58-43FD-8D47-E8991EB2B719Q36305699-DC1BBFC7-8698-4E14-A756-7C1AE6BA0968Q36461735-CB76CFB2-D214-4D9C-87F6-D44116F3A68FQ37095706-7E8A7593-E2D7-4487-9BB8-82B9B619FBE7Q37137527-8A4E13FD-0FEA-4E63-A607-C111AE1F6915Q37224888-B24949B4-51D4-4E80-ADFB-DCAFAB901F99Q37252908-D018F2F2-4B3F-44ED-8F12-CA8F45371592Q37406560-8AD54B57-9BA3-440C-84E5-9BB02092F7C0Q38271904-465C95DF-D736-4227-84CF-E72AA6469A2EQ38289552-AED84627-521C-439E-9B03-14B8964F559BQ38351585-D070745E-9471-4C51-8FDD-FB4D1DA4C281Q38560069-B3B846F7-69ED-41E9-A9CB-C0AB8F9E5B97Q38563251-2AB344E6-04FE-4483-BFE6-F16693F62459Q38566445-BFA5BF44-C63F-4CE0-923E-E82D949171F1Q38718207-9CF7FB1F-E17C-4B80-B8FD-69B3286C6CBCQ38733622-75AFB365-8B42-4812-AE6D-7ACC40D0BCF2Q38775846-6907E4D9-8820-4E67-817E-6DD855A21E81Q38793556-0966854F-23FE-48AE-BAB5-D0F7A5D085CCQ38795091-48A92BFE-465A-4AD6-9EE4-929E1D2566A9Q38826563-40E1F099-5BC6-475A-9ED4-F48FE22888E0Q39170332-D9754773-61B7-4DE1-B3F7-AF46203154ECQ40072840-105426DD-14CC-480F-A62B-1234D6F0A935Q40246829-CF9F996B-54C3-4E4A-A841-0DECA8CE5DE6Q40458714-9D7F8B16-40A6-428C-9FA1-1965FA512EE0Q40880775-B82CE814-B1CB-4435-8004-3F5EA0971454Q41651688-EB359F4B-36C2-41EB-A4E9-EEBD81A426F2
P2860
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@en
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@nl
type
label
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@en
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@nl
prefLabel
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@en
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@nl
P2093
P2860
P356
P1433
P1476
Viral entry of hepatitis B and ...... te cotransporting polypeptide.
@en
P2093
Guangwei Xu
Zhiyi Jing
P2860
P304
P356
10.1128/JVI.03478-13
P407
P577
2014-01-03T00:00:00Z